More J-Pharma Co.,Ltd. news
J-Pharma Co.,Ltd.TSE: 520A

J-Pharma Enters into Non-Binding Term Sheet with European Biotech Company for JPH034

Sep 24, 2026 at 7:00 PM EDT · Issued by J-Pharma Co.,Ltd. via TDnet

Filed with TSE · Sep 24, 2026 at 7:00 PM EDT · 4 pages · English

On 6ix: 6ix.com/news/j-pharma-enters-into-non-binding-term-sheet-with-european-biotech-company-for-jph034

J-Pharma Co.,Ltd. on 6ix

Earlier from J-Pharma Co.,Ltd

  • Non-consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)Aug 12
  • Notice Regarding Issuance of New Shares as Restricted Stock Compensation to Directors and Executive OfficersJul 13
  • Matters Relating to Business Plans and Growth PotentialJun 26

Later from J-Pharma Co.,Ltd

  • J-Pharma Selected for Funding under AMED's Global Research and Development Support Project for the Treatment of Intractable/Rare DiseasesOct 4
  • Notice of Grant approval and Commencement of the Grant-Funded Project under AMED’s GRiT ProgramOct 30
  • Non-consolidated Financial Results for the Six Months Ended September 30, 2026 (Under Japanese GAAP)Nov 11
  • Notice Regarding the Recognition of Non-operating Expenses (Foreign Exchange Losses)Nov 11
All J-Pharma Co.,Ltd news releases↗

Follow J-Pharma Co.,Ltd into a list and get an email when it puts out news.

Follow J-Pharma Co.,Ltd
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer